Ligand validation:4KDQ

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4KDQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4KDQ_NAG_E_502	81%	59%	0.104	0.957	0.53	1.02	-	2	2	0	100%	0.9333
4KDQ_NAG_A_502	59%	54%	0.136	0.916	0.47	1.27	-	1	2	0	100%	0.9333
4KDQ_NAG_C_502	52%	52%	0.13	0.886	0.4	1.44	-	4	1	0	100%	0.9333
4KDQ_NAG_E_501	26%	60%	0.156	0.797	0.59	0.95	-	1	0	0	100%	0.9333
4KDQ_NAG_C_501	25%	50%	0.187	0.822	0.67	1.25	-	3	0	0	100%	0.9333
4KDQ_NAG_A_501	21%	60%	0.199	0.81	0.48	1.05	-	1	0	0	100%	0.9333
4KDQ_NAG_E_503	9%	77%	0.228	0.71	0.29	0.61	-	-	2	0	100%	0.9333
4BH0_NAG_A_1320	84%	50%	0.074	0.935	0.49	1.4	-	2	0	0	100%	0.9333
4CR0_NAG_A_1165	83%	51%	0.112	0.97	0.49	1.37	-	1	0	0	100%	0.9333
4BGZ_NAG_C_503	71%	53%	0.082	0.901	0.45	1.34	-	2	0	0	100%	0.9333
4K64_NAG_A_601	70%	61%	0.125	0.942	0.51	0.97	-	1	0	0	100%	0.9333
4CQZ_NAG_A_1327	68%	57%	0.112	0.922	0.46	1.16	-	2	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.